NCT03069456

Brief Summary

The investigators want to compare the performance of anesthetic depth monitoring for sedation (ADMS) to the bispectral index (BIS) as electroencephalographic measures of sevoflurane effect using two combined sigmoidal Emax models via population pharmacodynamic approach.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

February 15, 2017

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 3, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

March 3, 2017

Status Verified

February 1, 2017

Enrollment Period

1.2 years

First QC Date

February 15, 2017

Last Update Submit

February 27, 2017

Conditions

Keywords

sevofluraneBistpectral indexAnesthetic Depth Monitoring Systempopulation pharmacodynamics

Outcome Measures

Primary Outcomes (2)

  • Bispectral Index (BIS)

    captured BIS data (0\~100) from the BIS system after induction of general anesthesia, sevoflurane concentrations will be progressively increased and then decreased over 70 min.

    Data capture will be started 45 minutes after induction of general anesthesia for 70 minutes

  • Anesthetic depth monitoring for sedation (ADMS)

    captured ADMS data (0\~100) from the ADMS system after induction of general anesthesia, sevoflurane concentrations will be progressively increased and then decreased over 70 min.

    Data capture will be started 45 minutes after induction of general anesthesia for 70 minutes

Secondary Outcomes (1)

  • Adverse events

    visit patients 24 hours after operation.

Study Arms (2)

BIS group

ACTIVE COMPARATOR

Combined sigmoidal Emax models from the BIS data

Device: BIS

ADMS group

EXPERIMENTAL

Combined sigmoidal Emax models from the ADMS data

Device: ADMS

Interventions

BISDEVICE
BIS group
ADMSDEVICE
ADMS group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patients scheduled for an elective operation and postoperative epidural PCA with ASA physical status 1,2,3 who have signed the wrtten informed consent.

You may not qualify if:

  • preventive anticoagulation treatment
  • Significant liver, kidney, coagulation dysfunction
  • Clinically significant ECG abnormalities
  • administration of psychologic durgs or opioid within 14 days before surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chonnam National University Hwasun Hospital

Hwasun, 519-763, South Korea

RECRUITING

Related Publications (3)

  • Han DW, Linares-Perdomo OJ, Lee JS, Kim JH, Kern SE. Comparison between cerebral state index and bispectral index as measures of electroencephalographic effects of sevoflurane using combined sigmoidal E(max) model. Acta Pharmacol Sin. 2011 Oct;32(10):1208-14. doi: 10.1038/aps.2011.99. Epub 2011 Sep 5.

    PMID: 21892201BACKGROUND
  • Kreuer S, Bruhn J, Wilhelm W, Grundmann U, Rensing H, Ziegeler S. Comparative pharmacodynamic modeling of desflurane, sevoflurane and isoflurane. J Clin Monit Comput. 2009 Oct;23(5):299-305. doi: 10.1007/s10877-009-9196-6. Epub 2009 Aug 27.

    PMID: 19711188BACKGROUND
  • Rehberg B, Bouillon T, Zinserling J, Hoeft A. Comparative pharmacodynamic modeling of the electroencephalography-slowing effect of isoflurane, sevoflurane, and desflurane. Anesthesiology. 1999 Aug;91(2):397-405. doi: 10.1097/00000542-199908000-00013.

    PMID: 10443602BACKGROUND

Study Officials

  • SEONGWOOK JEONG, MD, PhD.

    Chonnam National University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tae-hee Pyeon, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Combined sigmoidal Emax models from anesthetic depth monitoring for sedation (ADMS) and combined sigmoidal Emax models from bispectral index (BIS) via population pharmacodynamic approach.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

February 15, 2017

First Posted

March 3, 2017

Study Start

April 1, 2016

Primary Completion

June 1, 2017

Study Completion

December 1, 2017

Last Updated

March 3, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share

Locations